Dr Boyle is Associate Professor of Evidence-Based Dermatology at the University of Nottingham and Clinical Reader in Paediatric Allergy at Imperial College London. He trained in Paediatric Allergy and Immunology at the Royal Children's Hospital and Melbourne University, Australia where his PhD investigated the mechanisms through which dietary interventions may prevent eczema, and he undertook his first Cochrane systematic review.
Dr Boyle's current research is focussed on the primary prevention of allergic diseases, and an analysis of research integrity in the field of infant formula clinical trials.
Dr Boyle's recent work for the UK Food Standards Agency has influenced infant feeding guidance in the UK and internationally. Key findings were that early introduction of egg and peanut reduce risk of allergy to these foods JAMA, that there is no evidence to support recommending hydrolysed formula for prevention of allergic disease BMJ, and that specific maternal dietary supplements during pregnancy and lactation may reduce risk of allergic disease in young children PLOS Medicine. Full reports are on the Food Standards Agency website Timing of Allergenic Food Introduction , Hydrolysed Formula and Other Dietary Exposures and Interventions. Dr Boyle's current clinical trial work is focussed on the possibility that we may be able to prevent eczema and food allergy by improving infant skin care during the first months of life. He is leading food allergy assessment in the UK BEEP trial, and conducting a prospective meta-analysis of infant skin care studies for preventing allergic outcomes.
Dr Boyle works as Joint Coordinating Editor of the Cochrane Skin Group. He is Senior Editor of the Cochrane Children and Families Network, a Co-Editor of the journal Clinical and Experimental Allergy, and has developed a longitudinal learning course for undergraduate medical students called Follow my Footsteps.
TAM H, CALDERON MA, MANIKAM L, NANKERVIS H, GARCÍA NÚÑEZ I, WILLIAMS HC, DURHAM S and BOYLE RJ, 2016. Specific allergen immunotherapy for the treatment of atopic eczema. The Cochrane database of systematic reviews. 2, CD008774
BOYLE RJ, IERODIAKONOU D, KHAN T, CHIVINGE J, ROBINSON Z, GEOGHEGAN N, JARROLD K, AFXENTIOU T, REEVES T, CUNHA S, TRIVELLA M, GARCIA-LARSEN V and LEONARDI-BEE J, 2016. Hydrolysed formula and risk of allergic or autoimmune disease: systematic review and meta-analysis. BMJ (Clinical research ed.). 352, i974